Corvus Pharmaceuticals Inc. (CRVS)
Market Closed
17 Jul, 20:00
$
14. 90
+0.63
+4.4149%
$
1.26B Market Cap
- P/E Ratio
- Div Yield
780,700 Volume
-0.55 Eps
$ 14.27
Previous Close 
Want to track CRVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corvus Pharmaceuticals Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Paul Choi Goldman Sachs | 4,636.07 | $48,807.44 | $69,170.14 | $20,362.7 | 41.72% |
